Loading the section
Closing prices for 09 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
The series is stated in the current share scale after splits; dividends are not included in the price
Address:8 RUE DE LA CROIX JARRY, PARIS, LLE-DE-FRANCE
Cellectis S.A. trades on Nasdaq under the ticker CLLS. The company belongs to the Health care sector. The trading history on this page starts on 22 August 2016.
Over the past 52 weeks CLLS has traded between 1.22 $ and 5.48 $. As of 09 October 2026 the price stood 0.92 % of the way from the 52-week low to the high.
Over one year CLLS shares fell 70.70 %; over six months they fell 64.90 %. Volatility over 90 days is 110.96 %. Dividends are not included: this is price change only, as of 09 October 2026.
Cellectis S.A. reported revenue of 73M $ and a net loss of 68M $ for the latest fiscal year. Net margin is −92.66 %. Revenue changed by +75.76 % year over year. Earnings per share are −0.67 $.
CLLS has a return on equity of −89.05 %, below the sector median of −41.68 %. Return on assets is −20.82 %, above the sector median of −32.11 %. Operating margin is −45.34 %, below the sector median of −26.84 %.
| Security | Price, $ | Day change | Turnover 30d, $ |
|---|---|---|---|
| ARGXargenx SE | 825.03 | +0.78 % | 316M |
| BNTXBioNTech SE | 96.96 | +5.32 % | 97M |
| IMCRImmunocore Holdings plc | 29.39 | +1.03 % | 13M |
| SCNIScinai Immunotherapeutics Ltd. | 1.18 | −2.48 % | 5M |
| DBVTDBV Technologies S.A. | 9.80 | +2.62 % | 4M |
| MESOMesoblast Limited | 14.29 | +3.93 % | 3M |
| AUTLAutolus Therapeutics plc | 1.81 | +2.26 % | 3M |
| VALNValneva SE | 5.78 | +1.58 % | 190,558 |
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 09 October 2026 | 1.27 | 1.29 | 1.25 | 1.26 | 75,800 |
| 08 October 2026 | 1.28 | 1.31 | 1.22 | 1.25 | 106,800 |
| 07 October 2026 | 1.35 | 1.40 | 1.33 | 1.34 | 62,500 |
| 06 October 2026 | 1.42 | 1.44 | 1.37 | 1.40 | 75,800 |
| 05 October 2026 | 1.43 | 1.44 | 1.38 | 1.41 | 37,300 |
| 02 October 2026 | 1.45 | 1.47 | 1.42 | 1.43 | 46,800 |
| 01 October 2026 | 1.47 | 1.50 | 1.40 | 1.40 | 140,700 |
| 30 September 2026 | 1.48 | 1.53 | 1.47 | 1.51 | 67,400 |
| 29 September 2026 | 1.41 | 1.47 | 1.40 | 1.47 | 32,700 |
| 28 September 2026 | 1.47 | 1.50 | 1.43 | 1.48 | 58,100 |
| 25 September 2026 | 1.45 | 1.48 | 1.42 | 1.47 | 37,700 |
| 24 September 2026 | 1.41 | 1.45 | 1.36 | 1.43 | 68,800 |
| 23 September 2026 | 1.50 | 1.59 | 1.41 | 1.44 | 169,800 |
| 22 September 2026 | 1.53 | 1.62 | 1.53 | 1.56 | 76,300 |
| 21 September 2026 | 1.53 | 1.55 | 1.47 | 1.51 | 88,900 |
| 18 September 2026 | 1.48 | 1.55 | 1.45 | 1.53 | 249,500 |
| 17 September 2026 | 1.45 | 1.55 | 1.43 | 1.46 | 346,800 |
| 16 September 2026 | 1.43 | 1.51 | 1.25 | 1.38 | 672,300 |
| 15 September 2026 | 1.65 | 1.69 | 1.55 | 1.61 | 781,100 |
| 14 September 2026 | 2.32 | 2.42 | 1.75 | 1.83 | 1M |
Based on the fiscal year ended 31 December 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
Share count is a period average, so market cap is approximate.